Charles River Laboratories International, Inc.
CRLNYSE
Healthcare
$173.59
-1.31(-0.75%)
Mkt Cap $8.5B
$99.75
$226.77
52-Week Range
At a Glance
AI-generatedCharles River Laboratories International, Inc.
Revenue breakdown: Discovery And Safety Assessment Segment (61.3%), Research Models And Services Segment (20.2%), Manufacturing Support Segment (18.5%).
8-K
Charles River Laboratories International, Inc. filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Exhibit 99.1 press release. The information is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act.$8.5B
Market Cap
$4.0B
Revenue
-$144M
Net Income
Employees18,700
Fundamentals
How The Business Makes Money
Revenue by Segment
Discovery And Safety Assessment Segment61.3%($22.4B)
Research Models And Services Segment20.2%($7.4B)
Manufacturing Support Segment18.5%($6.8B)
Revenue by Geography
US55.2%($6.7B)
Europe26.7%($3.3B)
CA12.1%($1.5B)
Asia Pacific4.9%($603M)
Other1.1%($135M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001100682
ISINUS1598641074
CUSIP159864107
Phone781 222 6000
Address251 Ballardvale Street, Wilmington, MA, 01887, US
SEC EDGAR